200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 157115-85-0

157115-85-0

157115-85-0 | Glycine, 1-(2-phenylacetyl)-L-prolyl-, ethyl ester

CAS No: 157115-85-0 Catalog No: AG001P85 MDL No:MFCD00941121

Product Description

Catalog Number:
AG001P85
Chemical Name:
Glycine, 1-(2-phenylacetyl)-L-prolyl-, ethyl ester
CAS Number:
157115-85-0
Molecular Formula:
C17H22N2O4
Molecular Weight:
318.3676
MDL Number:
MFCD00941121
IUPAC Name:
ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate
InChI:
InChI=1S/C17H22N2O4/c1-2-23-16(21)12-18-17(22)14-9-6-10-19(14)15(20)11-13-7-4-3-5-8-13/h3-5,7-8,14H,2,6,9-12H2,1H3,(H,18,22)/t14-/m0/s1
InChI Key:
PJNSMUBMSNAEEN-AWEZNQCLSA-N
SMILES:
CCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)Cc1ccccc1
UNII:
4QBJ98683M

Properties

Complexity:
432  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
318.158g/mol
Formal Charge:
0
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
318.373g/mol
Monoisotopic Mass:
318.158g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
75.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.5  

Literature

Title Journal
Neuroprotective and nootropic drug noopept rescues α-synuclein amyloid cytotoxicity. Journal of molecular biology 20111216
[Peptidergic modulation of the hippocampus synaptic activity]. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20111101
Effects of nootropics on the EEG in conscious rats and their modification by glutamatergic inhibitors. Brain research bulletin 20110530
[Strategy for the development of dipeptide drugs]. Vestnik Rossiiskoi akademii meditsinskikh nauk 20110101
[Analysis of the binding capacity of the benzodiazepine site of gabaa receptor in mice C57BL/6 and BALB/C pretreated with anxiolytics]. Eksperimental'naia i klinicheskaia farmakologiia 20110101
[Noopept in the treatment of mild cognitive impairment in patients with stroke]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101
[On the mechanism of noopept action: decrease in activity of stress-induced kinases and increase in expression of neutrophines]. Eksperimental'naia i klinicheskaia farmakologiia 20101201
Novel nootropic dipeptide Noopept increases inhibitory synaptic transmission in CA1 pyramidal cells. Neuroscience letters 20100531
[Effect of the novel nootropic and neuroprotective dipeptide noopept on the streptozotocin-induced model of sporadic Alzheimer disease in rats]. Eksperimental'naia i klinicheskaia farmakologiia 20100101
Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin. Neuroscience and behavioral physiology 20090301
Noopept reduces the postischemic functional and metabolic disorders in the brain of rats with different sensitivity to hypoxia. Bulletin of experimental biology and medicine 20090301
Genotype-dependent characteristics of behavior in mice in cognitive tests. The effects of Noopept. Neuroscience and behavioral physiology 20090101
[Prevention of neuro- and cardiotoxic side effects of tuberculosis chemotherapy with noopept]. Klinicheskaia meditsina 20090101
[Efficacy of noopept in discirculatory encephalopathy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101
[The original nootropic and neuroprotective drug noopept potentiates the anticonvulsant activity of valproate in mice]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
Noopept stimulates the expression of NGF and BDNF in rat hippocampus. Bulletin of experimental biology and medicine 20080901
Original nootropic drug noopept prevents memory deficit in rats with muscarinic and nicotinic receptor blockade. Bulletin of experimental biology and medicine 20080701
Noopept efficiency in experimental Alzheimer disease (cognitive deficiency caused by beta-amyloid25-35 injection into Meynert basal nuclei of rats). Bulletin of experimental biology and medicine 20080701
[A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101
[Clinical and electroencephalographic characteristic of noopept in patients with mild cognitive impairment of posttraumatic and vascular origin]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101
[The using of noopept in treatment of neurasthenia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101
The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model. Journal of psychopharmacology (Oxford, England) 20070801
Immunopharmacological properties of noopept. Bulletin of experimental biology and medicine 20070701
Dipeptide preparation Noopept prevents scopolamine-induced deficit of spatial memory in BALB/c mice. Bulletin of experimental biology and medicine 20070401
[Effects of noopept and cortexin on the behavior of matured rats treated with corticoliberin or 70-kDa heat shock proteins in early ontogeny]. Eksperimental'naia i klinicheskaia farmakologiia 20070101
[Behavior of mice from different strains: modifications produced by noopept]. Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova 20070101
[Genotype-dependent mice behavior in cognitive tasks. Effect of noopept]. Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova 20070101
Studies of long-term noopept and afobazol treatment in rats with learned helplessness neurosis. Bulletin of experimental biology and medicine 20060801
[Neuroprotective activity of the proline-containing dipeptide noopept on the model of brain ischemia induced by the middle cerebral artery occlusion]. Eksperimental'naia i klinicheskaia farmakologiia 20060101
Early postnatal effects of noopept and piracetam on declarative and procedural memory of adult male and female rats. Bulletin of experimental biology and medicine 20050601
[Comparative study of the long-term behavioral effects of noopept and piracetam in adult male rats and female rats in postnatal period]. Eksperimental'naia i klinicheskaia farmakologiia 20050101
[Noopept improves the spatial memory and stimulates prefibrillar beta-amyloid(25-35) antibody production in mice]. Eksperimental'naia i klinicheskaia farmakologiia 20050101
Relationship between changes in rat behavior and integral biochemical indexes determined by laser correlation spectroscopy after photothrombosis of the prefrontal cortex. Bulletin of experimental biology and medicine 20040201
[Interspecies differences of noopept pharmacokinetics]. Eksperimental'naia i klinicheskaia farmakologiia 20040101
Effect of noopept and afobazole on the development of neurosis of learned helplessness in rats. Bulletin of experimental biology and medicine 20030801
Cyclopropyl glycine and proline-containing preparation noopept evoke two types of membrane potential responses in synaptoneurosomes. Bulletin of experimental biology and medicine 20030601
GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20030501
[Regulation of the neuronal functional state by ultra low doses of different biologically active substances. Nonspecific effect ]. Radiatsionnaia biologiia, radioecologiia 20030101
[Evolution of the neuroprotection concept]. Eksperimental'naia i klinicheskaia farmakologiia 20030101
[Pharmacological regulation of emotional stress reactions]. Vestnik Rossiiskoi akademii meditsinskikh nauk 20030101
Impairment of learning and memory after photothrombosis of the prefrontal cortex in rat brain: effects of Noopept. Bulletin of experimental biology and medicine 20021201
Selective suppression of the slow-inactivating potassium currents by nootropics in molluscan neurons. The international journal of neuropsychopharmacology 20020901
[Preclinical study of noopept toxicity]. Eksperimental'naia i klinicheskaia farmakologiia 20020101
[Effect of the novel dipeptide nootropic agent noopept and its metabolite cyclo-L-prolylglycine on the transcallosal evoked potential in the rat brain]. Eksperimental'naia i klinicheskaia farmakologiia 20020101
[Multicomponent antithrombotic effect of the neuroprotective prolyl dipeptide GVS-111 and its major metabolite cyclo-L-prolylglycine]. Eksperimental'naia i klinicheskaia farmakologiia 20020101
[Anti-inflammatory properties of noopept (dipeptide nootropic agent GVS-111)]. Eksperimental'naia i klinicheskaia farmakologiia 20020101
[The original novel nootropic and neuroprotective agent noopept]. Eksperimental'naia i klinicheskaia farmakologiia 20020101
[The role of non-NMDA glutamate receptors in the EEG effects of chronic administration of noopept GVS-111 in awake rats]. Eksperimental'naia i klinicheskaia farmakologiia 20020101
Proline-containing dipeptide GVS-111 retains nootropic activity after oral administration. Bulletin of experimental biology and medicine 20011001
[Behavioral and electrophysiological analysis of the choline-positive effect of nootropic dipeptide acylproline (GVS-111)]. Eksperimental'naia i klinicheskaia farmakologiia 20010101
[Effect of nootropic agents on impulse activity of cerebral cortex neurons]. Eksperimental'naia i klinicheskaia farmakologiia 20010101

Related Products

© 2019 Angene International Limited. All rights Reserved.